+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neurorehabilitation Devices Market Size, Share & Trends Analysis Report By Product (BCI, Wearable Devices, Neurorobotics), By Therapy Area (Stroke, Parkinson's Disease, Cerebral Palsy), By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 110 Pages
  • October 2023
  • Region: Global
  • Grand View Research
  • ID: 5899519
Description Jump to:
The global neurorehabilitation devices market size is anticipated to reach USD 4.98 billion by 2030, registering a CAGR of 13.9% from 2024 to 2030. Increasing emphasis on R&D for novel product launches, production of innovative technology & devices to enhance patient outcomes, advancements in medical technology, such as manufacturing of neuroprosthetic devices, including brain-computer interfaces (BCIs) and neurostimulation devices, and the increasing adoption of telemedicine & remote rehabilitation solutions drive the industry growth. The development of cutting-edge tools and technologies to improve patient outcomes also drives market growth. Greater financial resources are available to purchase cutting-edge neurorehabilitation equipment when healthcare costs rise.

Funds might be set aside for R&D in the neurorehabilitation sector by business players with sizable healthcare budgets. The development of novel and improved tools for neurological rehabilitation may result from this. For instance, in March 2023, SiYi Intelligence, a Chinese company that offers intelligent rehabilitation solutions, recently revealed that it had raised USD 15 billion in a Series A investment round, with participation from Tao Capital and Chengdu Bio-town Equity Investment Fund. The business intended to use the funds to advance the R&D of neurorehabilitation solution integration and create a new digital rehabilitation service platform. Major industry participants, such as manufacturers of medical devices, academic institutions, and healthcare providers are involved in the strategic collaborations and partnerships for product development.

R&D resources can be combined through collaborative efforts, promoting quicker inventions and the development of more efficient products. The technologies like virtual reality (VR) and AR are being used in neurorehabilitation. They can design therapeutic settings that are engaging, allowing patients to take part in stimulating activities that support the restoration of motor and cognitive abilities. Therapists can receive real-time feedback through VR and AR. For instance, in April 2023, the Office of Healthcare Innovation and Learning of the VHA (Veterans Health Administration) and Penumbra, Inc., a global healthcare company specializing in cutting-edge therapies, announced their collaboration to work together to test, co-develop, and implement VR-based rehabilitative healthcare solutions.

Neurorehabilitation Devices Market Report Highlights

  • In 2023, the neurorobotics segment dominated the market with a share of 36.0% due to the ongoing advancements in robotics and neurotechnology, which led to the development of more sophisticated and effective neurorobotic devices
  • The stroke therapy area segment held the largest revenue share of 44.3% in 2023. The use of home-based neurorehabilitation techniques is becoming more popular
  • The availability of rehabilitation services is increased via remote monitoring and telerehabilitation programs that enable stroke patients to continue their recovery in the convenience of their homes
  • North America dominated the global market with a share of 39.08% in 2023. The regional market is competitive due to the presence of a few established as well as emerging players
  • These companies strive to capture higher industry shares through product innovations, mergers, acquisitions, and partnerships

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Therapy area
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Therapy area outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Neurorehabilitation Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing incidence of neurological diseases
3.4.1.2. Technological advancements
3.4.1.3. Increasing clinical studies for the neurorehabilitation devices product development
3.4.2. Market restraint analysis
3.4.2.1. High cost of devices
3.4.2.2. Complex regulatory framework
3.5. Neurorehabilitation Devices Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Neurorehabilitation Devices Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Neurorobotics
4.1.2. Brain-Computer Interface
4.1.3. Wearable Devices
4.1.4. Non-Invasive Stimulators
4.1.5. Others
4.2. Product Market Share, 2023 & 2030
4.3. Segment Dashboard
4.4. Global Neurorehabilitation Devices Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Neurorobotics
4.5.1.1. Neurorobotics market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Brain-Computer Interface
4.5.2.1. Brain-computer interface market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Wearable Devices
4.5.3.1. Wearable devices market estimates and forecast 2018 to 2030 (USD Million)
4.5.4. Non-Invasive Stimulators
4.5.4.1. Non-invasive stimulators market estimates and forecast 2018 to 2030 (USD Million)
4.5.5. Others
4.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Neurorehabilitation Devices Market: Therapy Area Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Stroke
5.1.2. Parkinson’s Disease
5.1.3. Multiple Sclerosis
5.1.4. Cerebral Palsy
5.1.5. Others
5.2. Therapy area Market Share, 2023 & 2030
5.3. Segment Dashboard
5.4. Neurorehabilitation Devices Market by Therapy Area Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Stroke
5.5.1.1. Stroke market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Parkinson’s Disease
5.5.2.1. Parkinson’s disease market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Multiple Sclerosis
5.5.3.1. Multiple sclerosis market estimates and forecast 2018 to 2030 (USD Million)
5.5.4. Cerebral Palsy
5.5.4.1. Cerebral palsy market estimates and forecast 2018 to 2030 (USD Million)
5.5.5. Others
5.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Neurorehabilitation Devices Market: Regional Estimates & Trend Analysis
6.1. Regional market share analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Regional Market Share and Leading Players, 2023
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Latin America
6.4.5. Middle East and Africa
6.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
6.6. North America
6.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.6.2. U.S.
6.6.2.1. Key country dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory framework
6.6.2.4. Reimbursement scenario
6.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
6.6.3. Canada
6.6.3.1. Key country dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory framework
6.6.3.4. Reimbursement scenario
6.6.3.5. Canada market estimates and forecasts, 2018 - 2030
6.7. Europe
6.7.1. UK
6.7.1.1. Key country dynamics
6.7.1.2. Competitive Scenario
6.7.1.3. Regulatory framework
6.7.1.4. Reimbursement scenario
6.7.1.5. UK market estimates and forecasts, 2018 - 2030
6.7.2. Germany
6.7.2.1. Key country dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory framework
6.7.2.4. Reimbursement scenario
6.7.2.5. Germany market estimates and forecasts, 2018 - 2030
6.7.3. France
6.7.3.1. Key country dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory framework
6.7.3.4. Reimbursement scenario
6.7.3.5. France market estimates and forecasts, 2018 - 2030
6.7.4. Italy
6.7.4.1. Key country dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory framework
6.7.4.4. Reimbursement scenario
6.7.4.5. Italy market estimates and forecasts, 2018 - 2030
6.7.5. Spain
6.7.5.1. Key country dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory framework
6.7.5.4. Reimbursement scenario
6.7.5.5. Spain market estimates and forecasts, 2018 - 2030
6.7.6. Denmark
6.7.6.1. Key country dynamics
6.7.6.2. Competitive Scenario
6.7.6.3. Regulatory framework
6.7.6.4. Reimbursement scenario
6.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
6.7.7. Sweden
6.7.7.1. Key country dynamics
6.7.7.2. Competitive Scenario
6.7.7.3. Regulatory framework
6.7.7.4. Reimbursement scenario
6.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
6.7.8. Norway
6.7.8.1. Key country dynamics
6.7.8.2. Competitive Scenario
6.7.8.3. Regulatory framework
6.7.8.4. Reimbursement scenario
6.7.8.5. Norway market estimates and forecasts, 2018 - 2030
6.8. Asia Pacific
6.8.1. Japan
6.8.1.1. Key country dynamics
6.8.1.2. Competitive Scenario
6.8.1.3. Regulatory framework
6.8.1.4. Reimbursement scenario
6.8.1.5. Japan market estimates and forecasts, 2018 - 2030
6.8.2. India
6.8.2.1. Key country dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory framework
6.8.2.4. Reimbursement scenario
6.8.2.5. India market estimates and forecasts, 2018 - 2030
6.8.3. China
6.8.3.1. Key country dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory framework
6.8.3.4. Reimbursement scenario
6.8.3.5. China market estimates and forecasts, 2018 - 2030
6.8.4. South Korea
6.8.4.1. Key country dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory framework
6.8.4.4. Reimbursement scenario
6.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
6.8.5. Australia
6.8.5.1. Key country dynamics
6.8.5.2. Competitive Scenario
6.8.5.3. Regulatory framework
6.8.5.4. Reimbursement scenario
6.8.5.5. Australia market estimates and forecasts, 2018 - 2030
6.8.6. Thailand
6.8.6.1. Key country dynamics
6.8.6.2. Competitive Scenario
6.8.6.3. Regulatory framework
6.8.6.4. Reimbursement scenario
6.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
6.9. Latin America
6.9.1. Brazil
6.9.1.1. Key country dynamics
6.9.1.2. Competitive Scenario
6.9.1.3. Regulatory framework
6.9.1.4. Reimbursement scenario
6.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
6.9.2. Mexico
6.9.2.1. Key country dynamics
6.9.2.2. Competitive Scenario
6.9.2.3. Regulatory framework
6.9.2.4. Reimbursement scenario
6.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
6.9.3. Argentina
6.9.3.1. Key country dynamics
6.9.3.2. Competitive Scenario
6.9.3.3. Regulatory framework
6.9.3.4. Reimbursement scenario
6.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
6.10. MEA
6.10.1. South Africa
6.10.1.1. Key country dynamics
6.10.1.2. Competitive Scenario
6.10.1.3. Regulatory framework
6.10.1.4. Reimbursement scenario
6.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
6.10.2. Saudi Arabia
6.10.2.1. Key country dynamics
6.10.2.2. Competitive Scenario
6.10.2.3. Regulatory framework
6.10.2.4. Reimbursement scenario
6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
6.10.3. UAE
6.10.3.1. Key country dynamics
6.10.3.2. Competitive Scenario
6.10.3.3. Regulatory framework
6.10.3.4. Reimbursement scenario
6.10.3.5. UAE market estimates and forecasts, 2018 - 2030
6.10.4. Kuwait
6.10.4.1. Key country dynamics
6.10.4.2. Competitive Scenario
6.10.4.3. Regulatory framework
6.10.4.4. Reimbursement scenario
6.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Bioventus
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Ectron
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Hocoma
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Medtronic
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Tyromotion Inc.
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Abbott
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Biometrics Ltd
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Bionik Laboratories Corp. (BNKL)
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. BioXtreme Ltd.
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Ekso Bionics
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Product benchmarking
7.3.13.4. Strategic initiatives
7.3.14. Saebo, Inc
7.3.14.1. Company overview
7.3.14.2. Financial performance
7.3.14.3. Product benchmarking
7.3.14.4. Strategic initiatives
7.3.15. Kinova inc.
7.3.15.1. Company overview
7.3.15.2. Financial performance
7.3.15.3. Product benchmarking
7.3.15.4. Strategic initiatives
7.3.16. Kinestica
7.3.16.1. Company overview
7.3.16.2. Financial performance
7.3.16.3. Product benchmarking
7.3.16.4. Strategic initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global neurorehabilitation devices market, by region 2018-2030 (USD Million)
Table 4. Global neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 5. Global neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 6. North America neurorehabilitation devices market, by country, 2018-2030 (USD Million)
Table 7. North America neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 8. North America neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 9. U.S. neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 10. U.S. neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 11. Canada neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 12. Canada neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 13. Europe neurorehabilitation devices market, by country, 2018-2030 (USD Million)
Table 14. Europe neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 15. Europe neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 16. UK neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 17. UK neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 18. Germany neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 19. Germany neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 20. France neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 21. France neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 22. Italy neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 23. Italy neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 24. Spain neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 25. Spain neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 26. Denmark neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 27. Denmark neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 28. Sweden neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 29. Sweden neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 30. Norway neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 31. Norway neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 32. Asia Pacific neurorehabilitation devices market, by country, 2018-2030 (USD Million)
Table 33. Asia Pacific neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 34. Asia Pacific neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 35. Japan neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 36. Japan neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 37. China neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 38. China neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 39. India neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 40. India neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 41. Australia neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 42. Australia neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 43. Thailand neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 44. Thailand neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 45. South Korea neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 46. South Korea neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 47. Latin America neurorehabilitation devices market, by country, 2018-2030 (USD Million)
Table 48. Latin America neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 49. Latin America neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 50. Brazil neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 51. Brazil neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 52. Mexico neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 53. Mexico neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 54. Argentina neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 55. Argentina neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 56. MEA neurorehabilitation devices market, by country, 2018-2030 (USD Million)
Table 57. MEA neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 58. MEA neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 59. South Africa neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 60. South Africa neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 61. Saudi Arabia neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 62. Saudi Arabia neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 63. UAE neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 64. UAE neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
Table 65. Kuwait neurorehabilitation devices market, by product, 2018-2030 (USD Million)
Table 66. Kuwait neurorehabilitation devices market, by therapy area, 2018-2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Neurorehabilitation devices market: Market snapshot
Fig. 9 Neurorehabilitation devices market: Market segmentation
Fig. 10 Neurorehabilitation devices market Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Neurorehabilitation devices market driver impact
Fig. 14 Neurorehabilitation devices market restraint impact
Fig. 15 Neurorehabilitation devices market porter’s five forces analysis
Fig. 16 Neurorehabilitation devices market PESTEL analysis
Fig. 17 Neurorehabilitation devices market segment dashboard
Fig. 18 Neurorehabilitation devices market: Product movement Analysis
Fig. 19 Neurorobotics market estimates and forecast, 2018-2030 (USD Million)
Fig. 20 Brain-computer interface market estimates and forecast, 2018-2030 (USD Million)
Fig. 21 Wearable devices market estimates and forecast, 2018-2030 (USD Million)
Fig. 22 Non-invasive stimulators market estimates and forecast, 2018-2030 (USD Million)
Fig. 23 Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 24 Neurorehabilitation devices market: Therapy area movement Analysis
Fig. 25 Stroke market estimates and forecast, 2018-2030 (USD Million)
Fig. 26 Parkinson’s disease market estimates and forecast, 2018-2030 (USD Million)
Fig. 27 Multiple sclerosis market estimates and forecast, 2018-2030 (USD Million)
Fig. 28 Cerebral palsy market estimates and forecast, 2018-2030 (USD Million)
Fig. 29 Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 30 Global Neurorehabilitation devices market: Regional movement analysis
Fig. 31 Global Neurorehabilitation devices market: Regional outlook and key takeaways
Fig. 32 Global market share, by region
Fig. 33 North America market estimates and forecast, 2018-2030 (USD Million)
Fig. 34 U.S. market estimates and forecast, 2018-2030 (USD Million)
Fig. 35 Canada market estimates and forecast, 2018-2030 (USD Million)
Fig. 36 Europe market estimates and forecast, 2018-2030 (USD Million)
Fig. 37 UK market estimates and forecast, 2018-2030 (USD Million)
Fig. 38 Germany market estimates and forecast, 2018-2030 (USD Million)
Fig. 39 France market estimates and forecast, 2018-2030 (USD Million)
Fig. 40 Italy market estimates and forecast, 2018-2030 (USD Million)
Fig. 41 Spain market estimates and forecast, 2018-2030 (USD Million)
Fig. 42 Denmark market estimates and forecast, 2018-2030 (USD Million)
Fig. 43 Sweden market estimates and forecast, 2018-2030 (USD Million)
Fig. 44 Norway market estimates and forecast, 2018-2030 (USD Million)
Fig. 45 Asia Pacific market estimates and forecast, 2018-2030 (USD Million)
Fig. 46 Japan market estimates and forecast, 2018-2030 (USD Million)
Fig. 47 China market estimates and forecast, 2018-2030 (USD Million)
Fig. 48 India market estimates and forecast, 2018-2030 (USD Million)
Fig. 49 Australia market estimates and forecast, 2018-2030 (USD Million)
Fig. 50 Thailand market estimates and forecast, 2018-2030 (USD Million)
Fig. 51 South Korea market estimates and forecast, 2018-2030 (USD Million)
Fig. 52 Latin America market estimates and forecast, 2018-2030 (USD Million)
Fig. 53 Brazil market estimates and forecast, 2018-2030 (USD Million)
Fig. 54 Mexico market estimates and forecast, 2018-2030 (USD Million)
Fig. 55 Argentina market estimates and forecast, 2018-2030 (USD Million)
Fig. 56 Middle East and Africa. market estimates and forecast, 2018-2030 (USD Million)
Fig. 57 South Africa market estimates and forecast, 2018-2030 (USD Million)
Fig. 58 Saudi Arabia market estimates and forecast, 2018-2030 (USD Million)
Fig. 59 UAE market estimates and forecast, 2018-2030 (USD Million)
Fig. 60 Kuwait market estimates and forecast, 2018-2030 (USD Million)

Companies Mentioned

  • Bioventus
  • Ectron
  • Hocoma
  • Medtronic
  • Tyromotion Inc.
  • Abbott
  • Biometrics Ltd
  • Bionik Laboratories Corp. (BNKL)
  • BioXtreme Ltd.
  • Ekso Bionics
  • Saebo, Inc
  • Kinova inc.
  • Kinestica

Methodology

Loading
LOADING...

Related Topics

Related Reports

Neurorehabilitation Devices Market by Products, Therapy Area - Global Forecast 2025-2030 - Product Image

Neurorehabilitation Devices Market by Products, Therapy Area - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Neurorehabilitation Devices Market Analysis & Forecast to 2024-2034 - Product Image

Neurorehabilitation Devices Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Neurorehabilitation Devices - Global Strategic Business Report - Product Image

Neurorehabilitation Devices - Global Strategic Business Report

  • Report
  • 504 Pages
  • Global
From
Neurorehabilitation Devices Patent Landscape Report - Product Image

Neurorehabilitation Devices Patent Landscape Report

  • Report
  • 200 Pages
  • Global
From
Neurorehabilitation Devices Market Report by Product Type, Application, End User, and Region 2024-2032 - Product Image

Neurorehabilitation Devices Market Report by Product Type, Application, End User, and Region 2024-2032

  • Report
  • 141 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.